HOME >> BIOLOGY >> NEWS
Human-Like Ability, Categorical Perception, Found In Insects

biologists set up a cricket flight chamber, wired for sound, computerized data-gathering and a built-in breeze from a fan, to make the cricket think it is flying while tethered in midair. "We weren't looking for the so-called continuous perception," Wyttenbach said, explaining that continuous perception allows human color vision to discriminate hundreds of variations between "blue" and "green," even though humans cannot precisely label each bluish-sort-of-green color.

"A more useful ability in some situations is our ability to tell the difference between sounds like 'ba' and 'pa,' " Wyttenbach noted. "Even though there is a continuum of variation between 'ba' and 'pa' based on voice onset time or VOT, which instruments can detect, our ears don't discriminate. We hear either 'ba' or 'pa' and that's how we label it. That is categorical perception, and it looked like crickets might categorically perceive sounds as either 'other crickets' or 'bats.' "

Categorical perception previously had been shown at other laboratories in monkeys, chinchillas and some species of birds, Wyttenbach knew, but getting crickets to explain how they make up their minds would be tricky. His flight chamber experiments were showing that playback sounds mimicking cricket calls made the tethered insects "fly" toward the speaker. And sounds in the bat's ultrasound range made the crickets veer away from the speaker. Still, he couldn't very well ask the crickets: "Do 20 kHz and 40 kHz sound the same or different?"

So the neurobiologists turned to a test suggested by Cornell Professor of Psychology Elizabeth Spelke for another category of notoriously uncooperative research subjects, human babies. Spelke's habituation-dishabituation test determines precisely what stimulus level is "different enough" to get a subject's attention when it has grown accustomed to (or habituated to ) repeated stimuli. Babies respond less and less when they hear "pa" repeated over and over; they pay a
'"/>

Contact: Roger Segelken
hrs2@cornell.edu
607-255-9736
Cornell University News Service
13-Sep-1996


Page: 1 2 3

Related biology news :

1. Brown ecologist garners major National Science Foundation grant
2. APS Foundation names student travel award recipients
3. Institute for OneWorld Health receives Gates Foundation grant
4. National Parkinson Foundation designates UNC as Center of Excellence
5. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
6. Betty Ann Forbes wins 2004 ASM Founders Award
7. Leslie Ann Schiff wins 2004 Carski Foundation Award
8. Grant from GE Foundation to University of Houston to strengthen math, tech pipeline
9. National Foundation For Cancer Research names UCSDs Webster Cavenee NFCR Fellow
10. Founder of UCSD bioengineering program honored with lifetime achievement award
11. Green Foundation, Trust gives $12.8 million for UT Southwestern comprehensive research center

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Human Like Ability Categorical Perception Found Insects

(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... 17, 2014 Tigercat Pharma, Inc. today ... evaluating the investigational oral NK-1 receptor antagonist VPD-737 ... chronic itch who are unresponsive or inadequately responsive ... steroids and antihistamines. The primary ... Scale (VAS) itch score from baseline, comparing drug ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: